InVivium Capital

InVivium Capital is a venture capital firm dedicated to investing in transformative healthcare and life sciences innovations. Their mission is to collaborate with exceptional teams to bring groundbreaking technologies to life, aiming to make a meaningful impact on health and patient care. The firm focuses on sectors such as biotechnology, medical devices, tools and diagnostics, and healthcare IT, seeking solutions that provide significant value to patients, payers, providers, and the pharmaceutical and biotech industries. InVivium Capital's investment strategy spans the United States, with a willingness to consider opportunities in global and under-ventured geographies. They emphasize building deep, lasting relationships with entrepreneurs, offering a differentiated source of long-term capital and partnership. The team comprises experienced professionals with backgrounds in healthcare investing, committed to driving outsized, risk-adjusted returns for all stakeholders. InVivium Capital's approach is characterized by a disciplined focus, allowing them to tailor transaction structures and working relationships to meet the specific needs of each situation, thereby fostering operational excellence and maximizing value creation for future shareholders. Their portfolio includes investments in companies like Alto Neuroscience, demonstrating their commitment to supporting innovative solutions in the healthcare sector. The firm's philosophy centers on empowering entrepreneurs, creating jobs within underserved sectors, and building long-term financial assets through strategic partnerships and investments.